168 related articles for article (PubMed ID: 32031736)
1. Structural and biophysical characterization of the type VII collagen vWFA2 subdomain leads to identification of two binding sites.
Gebauer JM; Flachsenberg F; Windler C; Richer B; Baumann U; Seeger K
FEBS Open Bio; 2020 Apr; 10(4):580-592. PubMed ID: 32031736
[TBL] [Abstract][Full Text] [Related]
2. The vWFA2 domain of type VII collagen is responsible for collagen binding.
Wegener H; Leineweber S; Seeger K
Biochem Biophys Res Commun; 2013 Jan; 430(2):449-53. PubMed ID: 23237810
[TBL] [Abstract][Full Text] [Related]
3. Insight into interactions of the von-Willebrand-factor-A-like domain 2 with the FNIII-like domain 9 of collagen VII by NMR and SPR.
Leineweber S; Schönig S; Seeger K
FEBS Lett; 2011 Jun; 585(12):1748-52. PubMed ID: 21570975
[TBL] [Abstract][Full Text] [Related]
4. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita.
Iwata H; Bieber K; Tiburzy B; Chrobok N; Kalies K; Shimizu A; Leineweber S; Ishiko A; Vorobyev A; Zillikens D; Köhl J; Westermann J; Seeger K; Manz R; Ludwig RJ
J Immunol; 2013 Sep; 191(6):2978-88. PubMed ID: 23960233
[TBL] [Abstract][Full Text] [Related]
5. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.
Sesarman A; Mihai S; Chiriac MT; Olaru F; Sitaru AG; Thurman JM; Zillikens D; Sitaru C
Br J Dermatol; 2008 Mar; 158(3):463-71. PubMed ID: 18205879
[TBL] [Abstract][Full Text] [Related]
6. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.
Sitaru AG; Sesarman A; Mihai S; Chiriac MT; Zillikens D; Hultman P; Solbach W; Sitaru C
J Immunol; 2010 Feb; 184(3):1596-603. PubMed ID: 20038644
[TBL] [Abstract][Full Text] [Related]
7. A type VII collagen subdomain mutant is thermolabile and shows enhanced proteolytic degradability - Implications for the pathogenesis of recessive dystrophic epidermolysis bullosa?
Windler C; Hermsdorf U; Brinckmann J; Seeger K
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):52-59. PubMed ID: 27989960
[TBL] [Abstract][Full Text] [Related]
8. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.
Sitaru C; Chiriac MT; Mihai S; Büning J; Gebert A; Ishiko A; Zillikens D
J Immunol; 2006 Sep; 177(5):3461-8. PubMed ID: 16920988
[TBL] [Abstract][Full Text] [Related]
9. Chemical shift assignments of the fibronectin III like domains 7-8 of type VII collagen.
Hermsdorf U; Seeger K
Biomol NMR Assign; 2016 Apr; 10(1):53-5. PubMed ID: 26364055
[TBL] [Abstract][Full Text] [Related]
10. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.
Vorobyev A; Ujiie H; Recke A; Buijsrogge JJA; Jonkman MF; Pas HH; Iwata H; Hashimoto T; Kim SC; Hoon Kim J; Groves R; Samavedam U; Gupta Y; Schmidt E; Zillikens D; Shimizu H; Ludwig RJ
J Invest Dermatol; 2015 Jun; 135(6):1565-1573. PubMed ID: 25689103
[TBL] [Abstract][Full Text] [Related]
13. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
Front Immunol; 2019; 10():3012. PubMed ID: 31993051
[TBL] [Abstract][Full Text] [Related]
14. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.
Mihai S; Chiriac MT; Takahashi K; Thurman JM; Holers VM; Zillikens D; Botto M; Sitaru C
J Immunol; 2007 May; 178(10):6514-21. PubMed ID: 17475881
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Kromminga A; Hashimoto T; Bröcker EB; Zillikens D
Am J Pathol; 2002 Jul; 161(1):301-11. PubMed ID: 12107115
[TBL] [Abstract][Full Text] [Related]
17. Detection of collagen VII autoantibodies to NC1 and NC2 domains of collagen VII by ELISA in suspected epidermolysis bullosa acquisita and bullous lupus erythematosus patients.
Bain EE; Grover RK; Plunkett RW; Beutner EH
J Dermatol Sci; 2012 Feb; 65(2):155-6. PubMed ID: 22225828
[No Abstract] [Full Text] [Related]
18. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.
Sitaru C; Mihai S; Otto C; Chiriac MT; Hausser I; Dotterweich B; Saito H; Rose C; Ishiko A; Zillikens D
J Clin Invest; 2005 Apr; 115(4):870-8. PubMed ID: 15841176
[TBL] [Abstract][Full Text] [Related]
19. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita.
Chen M; Doostan A; Bandyopadhyay P; Remington J; Wang X; Hou Y; Liu Z; Woodley DT
Am J Pathol; 2007 Jun; 170(6):2009-18. PubMed ID: 17525268
[TBL] [Abstract][Full Text] [Related]
20. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
